Designation demonstrates highest level of commitment to quality health care.

Clinical Solutions VP (Remote) Looking for your next career move and want to help Prime Therapeutics (Prime) put more care in health care? Check out the Prime Careers Spotlight, a monthly roundup...

Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...

Enhanced strategic consultation and new products like Medicare Predictive Model and Enrollment Capabilities are changing Prime’s government programs and delivering better access and costs to members

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Tab 1 BEHAVIORAL HEALTH CORNER WEIGHT MANAGEMENT CORNER Clinical News EDITOR-IN-CHIEF: Maryam Tabatabai, PharmD EXECUTIVE EDITOR: Anna Schreck Bird, PharmD DEPUTY EDITORS: Erik Hamel, PharmD;...

A Q&A with Kristen Tveit, SVP, chief financial officer, Magellan Rx

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC tirzepatide (Zepbound)/Eli Lilly/SC T2DM Access the complete...

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Live updates from AMCP Annual Meeting

The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

The content in this publication is not a substitute for professional medical advice. For questions regarding any medical condition or if you need medical advice, please contact your health care...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

AIS Health

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Certification recognizes quality service and continuous improvement

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Nathan Downhour, senior vice president of strategic pharmacy solutions, led the implementation of Prime’s innovative Advocate+ care model

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey

Grant helps provide a home away from home for families facing cancer

In its annual fall report dedicated to oncology, Prime Therapeutics highlights strategies to improve outcomes, reduce costs and support patients — starting with a bold approach to managing cancer care

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

The event emphasizes additional measures for obesity therapy.

Payne to integrate communications, government affairs and policy efforts at leading purpose-driven, transparent PBM

At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Prime Therapeutics is committed to simplifying the patient journey for those with complex conditions through its industry-leading HighTouchRx product